Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets
OFFRE

Bayer : Shareholder Temasek Agrees to Increase Share Capital

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/17/2018 | 07:29am CEST

By Anthony Shevlin

Bayer said late Monday that investment company Temasek has signed an agreement to increase its share capital in the German company.

Temasek has subscribed to 31 million new Bayer shares, which equals around 3.6 percent of Bayer's capital stock, for 3 billion euros ($3.71 billion) in total gross proceeds, Bayer said.

Under the agreement, Bayer will issue the new registered--no par value--shares to a subsidiary of Temasek at market prices with an entitlement to dividends as of Jan. 1, 2017, the German company said.

Once the capital increase has been completed, and together with its existing shareholdings, Temasek will hold approximately 4 percent of Bayer's issued capital stock, Bayer said. The issued shares won't be subject to any lock-up period, it said.

Bayer Chief Executive Werner Baumann said the "investment affirms our business strategy including the proposed acquisition of Monsanto], as well as Bayer's strong growth prospects."

Write to Anthony Shevlin at anthony.shevlin@dowjones.com

Stocks mentioned in the article
ChangeLast1st jan.
BAYER -0.48% 76.15 Delayed Quote.-25.23%
MONSANTO 0.00%-End-of-day quote.9.57%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
09/24BAYER : Compugen Announces Clinical Milestone Payment in Cancer Immunotherapy Co..
AQ
09/22BAYER : Receives Positive CHMP Opinion for Its Hemophilia a Treatment BAY94-9027
AQ
09/22BAYER : Jivi Approved in Japan for Hemophilia a
AQ
09/21BAYER : collaborates with One Acre Fund to support smallholders in Africa with a..
AQ
09/20BAYER : "Fungicidal Compositions And Methods" in Patent Application Approval Pro..
AQ
09/20MONSANTO : Patent Issued for Plants And Seeds Of Hybrid Corn Variety CH624975 (U..
AQ
09/20BAYER : Compugen earns $7.8m payment from Bayer
AQ
09/20MONSANTO : Patent Application Titled "Containerized Liquid Formulations" Publish..
AQ
09/20MONSANTO : Patent Issued for Plants And Seeds Of Hybrid Corn Variety CH895408 (U..
AQ
09/20MONSANTO : Patent Issued for Plants And Seeds Of Hybrid Corn Variety CH618122 (U..
AQ
More news
News from SeekingAlpha
09/24DowDuPont And Bayer, Post-Merger Opportunities? 
09/21Feds looking into free services from drug makers - WSJ 
09/21Bayer's Jivi OK'd in Japan for hemophilia A 
09/20Compugen receives milestone payment in cancer immunotherapy collaboration wit.. 
09/19Bayer steps up legal fight over weedkiller, asks court to toss $289M jury awa.. 
Financials (€)
Sales 2018 39 117 M
EBIT 2018 7 261 M
Net income 2018 4 971 M
Debt 2018 39 658 M
Yield 2018 3,70%
P/E ratio 2018 15,10
P/E ratio 2019 14,12
EV / Sales 2018 2,84x
EV / Sales 2019 2,28x
Capitalization 71 359 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 102 €
Spread / Average Target 33%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER-25.23%83 828
JOHNSON & JOHNSON2.26%383 312
PFIZER21.65%258 285
NOVARTIS-0.63%216 108
ROCHE HOLDING LTD.-4.60%211 501
MERCK AND COMPANY26.36%189 092